Search Results - "Brutus, Jamila"

Reduced Dose Brentuximab Vedotin for Mycosis Fungoides Appears to Prolong Response Duration By Balancing Efficacy and Tolerability by Munayirji, Brittney, Khan, Niloufer, Myskowski, Patricia, Geller, Shamir, Noor, Sarah, Kheterpal, Meenal Kapoor, Davey, Theresa, Hancock, Helen, Perez, Leslie, Miller, Tayler, Brutus, Jamila, Ganesan, Nivetha, Chang, Tiffany, Mangiaracina, Gianna, Patel, Richa, Galasso, Natasha, Casper, Ellie, Ghione, Paola, Stuver, Robert, Epstein-Peterson, Zachary D., Pulitzer, Melissa, Khodadoust, Michael S., Kim, Youn H., Horwitz, Steven M., Moskowitz, Alison

“…Introduction: Brentuximab vedotin (BV) is one of the most active systemic agents for treating mycosis fungoides (MF); however, treatment duration and the…”
Get full text

Ruxolitinib Promotes Clinical Responses in Large Granular Lymphocytic Leukemia Via Suppression of JAK/STAT-Dependent Inflammatory Cascades by Moskowitz, Alison, Rahman, Jahan, Ganesan, Nivetha, Hannigan, Kelly, Ksanznak, Katie, Bitton, Hadassah, Lin, Ya-Hui, Davey, Theresa, Hancock, Helen, Perez, Leslie, Miller, Tayler, Brutus, Jamila, Dogan, Ahmet, Geyer, Mark Blaine, Jacobsen, Eric, Kumar, Anita, Moreira, Jonathan, Park, Jae H., Thompson, Meghan C., Torka, Pallawi, Zelenetz, Andrew D., Vardhana, Santosha A, Horwitz, Steven M.

“…Background: Large granular lymphocytic leukemias (LGL) are T or NK-cell lymphoproliferative disorders that are characterized by myelosuppression and frequent…”
Get full text